These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15892649)

  • 1. Type 2 diabetes as a lipid disorder.
    Taskinen MR
    Curr Mol Med; 2005 May; 5(3):297-308. PubMed ID: 15892649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic dyslipidaemia: from basic research to clinical practice.
    Taskinen MR
    Diabetologia; 2003 Jun; 46(6):733-49. PubMed ID: 12774165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes.
    Vergès B
    Atherosclerosis; 2010 Aug; 211(2):353-60. PubMed ID: 20189175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
    Adiels M; Olofsson SO; Taskinen MR; Borén J
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1225-36. PubMed ID: 18565848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of plasma triglycerides in insulin resistance and diabetes.
    Ginsberg HN; Zhang YL; Hernandez-Ono A
    Arch Med Res; 2005; 36(3):232-40. PubMed ID: 15925013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
    Festa A; Williams K; Hanley AJ; Otvos JD; Goff DC; Wagenknecht LE; Haffner SM
    Circulation; 2005 Jun; 111(25):3465-72. PubMed ID: 15983261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial VLDL-TG metabolism in type 2 diabetes.
    Søndergaard E; Johansen RF; Jensen MD; Nielsen S
    Metabolism; 2017 Oct; 75():25-35. PubMed ID: 28964326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyslipidemia in diabetes mellitus.
    Yoshino G; Hirano T; Kazumi T
    Diabetes Res Clin Pract; 1996 Jun; 33(1):1-14. PubMed ID: 8877270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic dyslipidaemia.
    Adiels M; Olofsson SO; Taskinen MR; Borén J
    Curr Opin Lipidol; 2006 Jun; 17(3):238-46. PubMed ID: 16680028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R; Taher J; Baker C; Adeli K; Su Q
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic dyslipidemia.
    Chahil TJ; Ginsberg HN
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):491-510, vii-viii. PubMed ID: 16959582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes.
    Orchard TJ; Cariou B; Connelly MA; Otvos JD; Zhang S; Antalis CJ; Ivanyi T; Hoogwerf BJ
    Cardiovasc Diabetol; 2017 Jun; 16(1):73. PubMed ID: 28587667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes.
    Bach-Ngohou K; Ouguerram K; Nazih H; Maugère P; Ripolles-Piquer B; Zaïr Y; Frénais R; Krempf M; Bard JM
    Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1451-8. PubMed ID: 12439646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overproduction of large VLDL particles is driven by increased liver fat content in man.
    Adiels M; Taskinen MR; Packard C; Caslake MJ; Soro-Paavonen A; Westerbacka J; Vehkavaara S; Häkkinen A; Olofsson SO; Yki-Järvinen H; Borén J
    Diabetologia; 2006 Apr; 49(4):755-65. PubMed ID: 16463046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
    Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L
    Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
    Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
    Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dyslipidemia].
    Kihara S
    Nihon Rinsho; 2013 Feb; 71(2):275-9. PubMed ID: 23631206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.